A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...

Discover how the medicinal orchid Dendrobium officinale (Tiepi Shihu) improves salivary gland function, reduces inflammation, and rebalances oral microbiota in nasopharyngeal cancer patients ...

China-based Kelun-Biotech Biopharmaceutical has received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed ...

Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...

HMPV virus is not a novel virus - It was first isolated in 2001 by Van den Hoogen and her colleagues in Netherlands in the ...

CHENGDU, China I January 20, 2025 I Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) has received marketing authorization in China from ...

Nasal cancer, which is also known as nasopharyngeal cancer, affects the nasopharynx, the upper part of the throat and can be easily mistaken for other problems ...

Shanghai Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel ...

Patients had a higher risk of death if they received radiotherapy in the afternoon or at night. Receiving radiotherapy in the morning may improve survival in patients with nasopharyngeal carcinoma ...

K2024-286-01), and patient informed consent was deemed unnecessary, given its retrospective nature. Fig 1. Study profile for the time-of-day patterns of radiotherapy in nasopharyngeal carcinoma. IMRT, ...

Background: Hypothyroidism is a common sequela after radiotherapy for nasopharyngeal carcinoma (NPC). Magnetic resonance imaging (MRI) has gained prominence in thyroid imaging, leveraging its ...